HomeClinical TopicsFDA approves new type of drug for insomnia
Clinical TopicsDrugs and DevicesNewsWeb Exclusives

FDA approves new type of drug for insomnia

On August 13, the U.S. Food and Drug Administration (FDA) approved Belsomra (suvorexant) tablets for treating insomnia. Belsomra is the first approved orexin receptor antagonist. Read more

Previous articleStudy: Smaller physician practices have lower preventable readmissions
Next articleFDA approves new device that may boost number of lung transplants

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content

For Nurse Practitioners

Pregnant woman drinking coffee

Cup of Coffee Can Lessen Gestational Diabetes Risk

Pregnant mothers concerned about being able to safely enjoy their morning cup of coffee should be reassured by a recent University of Pennsylvania study...

Powered by  HCM   www.HealthComMedia.com

© 2021 HealthCom Media All rights reserved. No part of this website or publication may be reproduced, stored, or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the copyright holder.